Developing Monoclonal Antibodies
Calico Biolabs, Inc. opened it's doors initially in the South of Market neighborhood of San Francisco, California in 2013. Then, in 2014, Calico opened up a subsidiary in Bayer's CoLaborator in Berlin
The company’s business is focused on contract antibody development for pharmaceutical and diagnostic companies, and for private and public research laboratories.
Calico also actively pursues its own research and development interests, focused on improving its core technology, high-throughput antibody screening, and the development of antibodies against novel cancer targets as companion diagnostics.
Supporting your Biomarker development